Fig. 1 · Structure
Documents & Downloads
Bitolterol mesylate
Bronchodilator
Bitolterol mesylate acts primarily as a bronchodilator, functioning through its properties as a diester-type agonist amine. This compound enhances airway patency by relaxing bronchial smooth muscle, making it valuable in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its profile indicates a low incidence of significant cardiac side effects, positioning it as a useful option in respiratory therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 30392-41-7 |
| Applications | Bronchodilator |
| Formula | C29H35NO8S |
| Molecular Weight | 557.66 |
| Synonyms | Win 32784; Bitolterol methanesulfonate; S-1540 mesylate |
| SMILES | OC(C1=CC=C(OC(C2=CC=C(C)C=C2)=O)C(OC(C3=CC=C(C)C=C3)=O)=C1)CNC(C)(C)C.CS(=O)(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.